Skip to main content
OpenTrials

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

3,010 public trials 644 recruiting studies
Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Recruiting

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

NCT07218380

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • The University of Arizona Cancer Center - North Campus Tucson, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Chao Family Comprehensive Cancer Center and Ambulatory Care (CIACC) - Irvine Irvine, California, United States
  • TRIO-US (Translational Research in Oncology-US) Los Angeles, California, United States
View all 284 locations
View Trial Details
Recruiting

Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial

NCT06770582

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +11 more
Locations
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • Highlands Oncology Group - Rogers Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • AIS Cancer Center at San Joaquin Community Hospital Bakersfield, California, United States
View all 140 locations
View Trial Details
Recruiting

A Study of Surgical Techniques During Cystectomy

NCT06703476

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Memorial Sloan Kettering at Basking Ridge (Consent Only) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Consent Only) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Consent Only) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk-Commack (Consent Only) Commack, New York, United States
View Trial Details
Recruiting

Trial of Zanzalintinib (XL092) in Combination With Immunotherapy in Patients Who Progress on Adjuvant Therapy in Clear Cell RCC

NCT06863311

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Carcinoma, +16 more
Locations
  • University of California San Diego La Jolla, California, United States
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Columbia University Irving Medical Center New York, United States
View Trial Details
Recruiting

Prospective Bladder Cancer Infrastructure (ProBCI)

NCT04503577

Conditions
Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Jeroen Bosch Hospital 's-Hertogenbosch, Netherlands
  • ZGT Almelo, Netherlands
  • Meander Medical Center Amersfoort, Netherlands
  • Amsterdam UMC, location VUMC Amsterdam, Netherlands
View all 23 locations
View Trial Details

Related conditions